CECR1 mutations, which cause deficiency of adenosine deaminase 2 (DADA2), are associated with cytopenias—including AIHA, thrombocytopenia, and severe neutropenia—that may occasionally be the initial clinical presentation [30]. Here, ADA2 is linked to Thrombocytopenia.